Norman Selby, Vice Chairman

Norman C. Selby has spent 35 years in the healthcare world in a variety of consulting, managerial, investor and Board roles. His primary activity today is serving as Executive Chairman of Real Endpoints. He is also Chairman of Paige.AI, the leading artificial intelligence company in pathology, and Lead Director of Infinity Pharmaceuticals (INFI), a public biotech company focused on oncology. Among earlier roles, Mr. Selby has served as the CEO of TransForm Pharmaceuticals, Executive Chairman of Windhover Information, Founder and Executive Chairman of Physicians Interactive Holdings, and Board member of Millennium Pharmaceuticals.

Mr. Selby spent the bulk of his career at McKinsey & Company where he was Director and Senior Partner in the firm’s New York office, and head of the firm’s Global Pharmaceuticals and Medical Products Practice. From 1987 to 1989, Mr. Selby took a leave of absence from McKinsey to serve as Chief Operating Officer of the New York Blood Center, the largest community blood organization in the country, where he led its financial and operational turnaround.

Mr. Selby serves on the Board of Trustees of the Central Park Conservancy and the Memorial Sloan-Kettering Cancer Center, and is a member of the Council on Foreign Relations, all based in New York City. He is also on the Advisory Board of the Harvard Business School’s Healthcare Initiative. Mr. Selby holds a BA in Architecture from Yale College and an MBA with Distinction from the Harvard Graduate School of Business Administration.

Our Team

Jeffrey Berkowitz

CEO and Director

Mr. Berkowitz is one of the rare top executives whose career has spanned most key verticals in global healthcare -- with executive committee and....

read full biography >

Susan Raiola


Susan Raiola is the President of Real Endpoints. Ms. Raiola has over 10 years of experience in the pharmaceutical consulting...

read full biography >

Roger Longman


Mr. Longman is recognized as an expert in biopharmaceutical strategy and reimbursement and often speaks at key...

read full biography >

Norman Selby

Vice Chairman

Norman C. Selby has spent 35 years in the healthcare world in a variety of consulting, managerial, investor and Board roles...

read full biography >

Jane F. Barlow, MD, MPH, MBA

EVP & Chief Clinical Officer

Jane Barlow is a clinical and strategic executive with over 25 years of healthcare leadership...

read full biography >

Beth Nash, MD

Chief Medical Officer

Dr. Beth Nash is Chief Medical Officer at Real Endpoints, where her team of pharmacists and biostatisticians has developed...

read full biography >

Heather Ritchie

VP, Product Strategy and Development

Heather Ritchie is VP Product Strategy and Development at Real Endpoints. She works closely with our customers and partners...

read full biography >

Jane Borne, RPh

VP, Pharmacy

Jane Borne, RPh, is responsible for ensuring the clinical credibility and evidence basis of all RE drug evaluation activities...

read full biography >

Amy Steinkellner, PharmD

Senior Consultant

Amy Steinkellner, PharmD, has worked with the Real Endpoint team since 2012. She serves as senior clinical advisor to the research...

read full biography >

Robert Galvin, MD

Dr. Robert Galvin is the Chief Executive Officer of Equity Healthcare (EH), which oversees the management of health care for firms...

read full biography >

Michael Sherman, MD

Dr. Michael Sherman serves as Chief Medical Officer and senior vice president for Harvard Pilgrim Health Care...

read full biography >

Dennis Purcell

Dennis is the Founder, Senior Advisor, and previous Senior Managing Partner of Aisling Capital LLC.,  a leading investment firm...

read full biography >

Linda Blackerby

Linda has been serving as the President of Pharma Intelligence at Informa since May 2015, overseeing an income statement...

read full biography >

Arthur Pappas (Observer)

Art has over 30 years of experience as a pharmaceutical industry executive and venture capital investor in...

read full biography >